Medicus Pharma Ltd. is a clinical-stage biotech company focused on accelerating the development of novel therapeutic assets. Their lead subsidiary, SkinJect Inc., is developing a non-invasive treatment for basal cell carcinoma using a dissolvable microneedle patch to deliver chemotherapeutic agents directly to tumor cells.